Alistair Chesser

759 total citations
21 papers, 527 citations indexed

About

Alistair Chesser is a scholar working on Nephrology, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Alistair Chesser has authored 21 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 8 papers in Public Health, Environmental and Occupational Health and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Alistair Chesser's work include Dialysis and Renal Disease Management (5 papers), Palliative Care and End-of-Life Issues (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Alistair Chesser is often cited by papers focused on Dialysis and Renal Disease Management (5 papers), Palliative Care and End-of-Life Issues (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Alistair Chesser collaborates with scholars based in United Kingdom and Germany. Alistair Chesser's co-authors include Jennifer Cleland, Muhammad M. Yaqoob, Sally Hull, Gavin Dreyer, Zoe Aitken, L. R. I. Baker, M. Comer, David D’Cruz, Miriam Hurst and A. E. G. Raine and has published in prestigious journals such as Kidney International, Clinical Chemistry and Nephrology Dialysis Transplantation.

In The Last Decade

Alistair Chesser

21 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alistair Chesser United Kingdom 12 204 112 89 69 62 21 527
Carles Forné Spain 13 147 0.7× 62 0.6× 134 1.5× 20 0.3× 29 0.5× 41 712
Verna Yiu Canada 15 136 0.7× 266 2.4× 65 0.7× 44 0.6× 39 0.6× 25 700
Shayan Shirazian United States 12 40 0.2× 257 2.3× 120 1.3× 52 0.8× 54 0.9× 26 740
Ermeg L. Akylbekova United States 14 109 0.5× 126 1.1× 24 0.3× 136 2.0× 267 4.3× 21 846
Devika Nair United States 15 92 0.5× 134 1.2× 23 0.3× 118 1.7× 86 1.4× 43 665
Rachel Bregman Brazil 14 126 0.6× 246 2.2× 25 0.3× 39 0.6× 56 0.9× 46 655
Shuo‐Chun Weng Taiwan 12 33 0.2× 97 0.9× 48 0.5× 39 0.6× 62 1.0× 45 428
K Weiss United States 9 40 0.2× 32 0.3× 73 0.8× 26 0.4× 81 1.3× 14 661
Juan C. Mason United Kingdom 7 182 0.9× 128 1.1× 66 0.7× 8 0.1× 25 0.4× 11 771
Hilary H. Colwell United States 17 134 0.7× 44 0.4× 40 0.4× 86 1.2× 12 0.2× 39 848

Countries citing papers authored by Alistair Chesser

Since Specialization
Citations

This map shows the geographic impact of Alistair Chesser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alistair Chesser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alistair Chesser more than expected).

Fields of papers citing papers by Alistair Chesser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alistair Chesser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alistair Chesser. The network helps show where Alistair Chesser may publish in the future.

Co-authorship network of co-authors of Alistair Chesser

This figure shows the co-authorship network connecting the top 25 collaborators of Alistair Chesser. A scholar is included among the top collaborators of Alistair Chesser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alistair Chesser. Alistair Chesser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harwood, Steven, Alistair Chesser, Martin Raftery, & Muhammad M. Yaqoob. (2016). Myocardial bioenergetic abnormalities in experimental uremia. International Journal of Nephrology and Renovascular Disease. 9. 129–129. 2 indexed citations
2.
Steddon, Simon, Alistair Chesser, John M. Cunningham, & Neil Ashman. (2014). Oxford Handbook of Nephrology and Hypertension. Oxford University Press eBooks. 17 indexed citations
3.
Dreyer, Gavin, Sally Hull, Rohini Mathur, Alistair Chesser, & Muhammad M. Yaqoob. (2013). Progression of chronic kidney disease in a multi‐ethnic community cohort of patients with diabetes mellitus. Diabetic Medicine. 30(8). 956–963. 32 indexed citations
4.
Hull, Sally, Gavin Dreyer, Ellena Badrick, Alistair Chesser, & Muhammad M. Yaqoob. (2011). The relationship of ethnicity to the prevalence and management of hypertension and associated chronic kidney disease. BMC Nephrology. 12(1). 41–41. 31 indexed citations
5.
McAdoo, Stephen P., et al.. (2011). Measuring the quality of end of life management in patients with advanced kidney disease: results from the pan-Thames renal audit group. Nephrology Dialysis Transplantation. 27(4). 1548–1554. 31 indexed citations
6.
Chesser, Alistair, et al.. (2009). Sources of variation in performance on a shared OSCE station across four UK medical schools. Medical Education. 43(6). 526–532. 38 indexed citations
7.
Dreyer, Gavin, Sally Hull, Zoe Aitken, Alistair Chesser, & Muhammad M. Yaqoob. (2009). The effect of ethnicity on the prevalence of diabetes and associated chronic kidney disease. QJM. 102(4). 261–269. 73 indexed citations
8.
9.
Noble, Helen, et al.. (2007). Developing a renal service for patients opting not to dialyse. 1(3). 51–55. 3 indexed citations
10.
Chesser, Alistair, et al.. (2007). A student‐led programme to raise awareness of organ donation. The Clinical Teacher. 4(3). 165–169. 3 indexed citations
11.
Chesser, Alistair, et al.. (2006). Analysis of predictors of success in the MRCP (UK) PACES examination in candidates attending a revision course. Postgraduate Medical Journal. 82(964). 145–149. 24 indexed citations
12.
Noble, Helen, Alistair Chesser, & Daniel Kelly. (2005). THE CESSATION OF DIALYSIS IN PATIENTS WITH END-STAGE RENAL DISEASE: DEVELOPING AN APPROPRIATE EVIDENCE BASE FOR PRACTICE. EDTNA-ERCA Journal. 31(4). 208–211. 11 indexed citations
13.
14.
Chesser, Alistair, et al.. (2004). Factor analysis can be a useful standard setting tool in a high stakes OSCE assessment. Medical Education. 38(8). 825–831. 31 indexed citations
15.
New, David, Alistair Chesser, Raj Thuraisingham, & Magdi Yaqoob. (2004). Structural remodeling of resistance arteries in uremic hypertension. Kidney International. 65(5). 1818–1825. 21 indexed citations
16.
Harwood, Steven, D. A. Allen, Alistair Chesser, et al.. (2003). Calpain is activated in experimental uremia: Is calpain a mediator of uremia-induced myocardial injury?. Kidney International. 63(3). 866–877. 10 indexed citations
17.
New, David, Alistair Chesser, Martin Raftery, & Magdi Yaqoob. (2003). The myogenic response in uremic hypertension. Kidney International. 63(2). 642–646. 7 indexed citations
18.
Fredericks, Salim, Joanne F. Murray, Nicholas D. Carter, et al.. (2002). Cardiac Troponin T and Creatine Kinase MB Content in Skeletal Muscle of the Uremic Rat. Clinical Chemistry. 48(6). 859–868. 8 indexed citations
19.
Chesser, Alistair, et al.. (1997). Technetium-99m methoxy isobutyl isonitrile (MIBI) imaging of the parathyroid glands in patients with renal failure. Nephrology Dialysis Transplantation. 12(1). 97–100. 21 indexed citations
20.
D’Cruz, David, Alistair Chesser, M. Comer, et al.. (1995). ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-POSITIVE CRESCENTIC GLOMERULONEPHRITIS ASSOCIATED WITH ANTI-THYROID DRUG TREATMENT. Lara D. Veeken. 34(11). 1090–1091. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carles Forné Breakdown of academic impact, for papers by Verna Yiu Breakdown of academic impact, for papers by Shayan Shirazian Breakdown of academic impact, for papers by Ermeg L. Akylbekova Breakdown of academic impact, for papers by Devika Nair Breakdown of academic impact, for papers by Rachel Bregman Breakdown of academic impact, for papers by Shuo‐Chun Weng Breakdown of academic impact, for papers by K Weiss Breakdown of academic impact, for papers by Juan C. Mason Breakdown of academic impact, for papers by Hilary H. Colwell
Rankless by CCL
2026